GlaxoSmithKline Consumer Nigeria Plc

NGSE:GLAXOSMITH Stock Report

Market Cap: ₦20.3b

GlaxoSmithKline Consumer Nigeria Past Earnings Performance

Past criteria checks 2/6

GlaxoSmithKline Consumer Nigeria's earnings have been declining at an average annual rate of -1.9%, while the Pharmaceuticals industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 3.1% per year. GlaxoSmithKline Consumer Nigeria's return on equity is 7.9%, and it has net margins of 4.6%.

Key information

-1.9%

Earnings growth rate

-1.8%

EPS growth rate

Pharmaceuticals Industry Growth21.6%
Revenue growth rate3.1%
Return on equity7.9%
Net Margin4.6%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How GlaxoSmithKline Consumer Nigeria makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NGSE:GLAXOSMITH Revenue, expenses and earnings (NGN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2315,8497366,6090
30 Jun 2318,3227625,3240
31 Mar 2322,0417325,6850
31 Dec 2225,3827716,0010
30 Sep 2226,4231,0205,5290
30 Jun 2227,3999485,9610
31 Mar 2226,3481,0915,7560
31 Dec 2122,4506595,3670
30 Sep 2121,3013115,5210
30 Jun 2120,7262905,2920
31 Mar 2119,7672645,0210
31 Dec 2021,2956225,1140
30 Sep 2021,2929245,3970
30 Jun 2021,2279375,2220
31 Mar 2020,7369355,3820
31 Dec 1920,7609175,2620
30 Sep 1920,3536935,4830
30 Jun 1919,7826285,3540
31 Mar 1919,2114625,3430
31 Dec 1818,4116185,3430
30 Sep 1818,5781,4904,3910
30 Jun 1817,2298274,5190
31 Mar 1816,4547534,4940
31 Dec 1716,0904864,5170
30 Sep 1715,0619,4473,8570
30 Jun 1714,9973,6124,0040
31 Mar 1714,0822,2543,4950
31 Dec 1614,3852,3783,4370
30 Sep 163,160-7,3349550
30 Jun 166,789-6361,6740
31 Mar 1612,0886922,9610
31 Dec 1515,3928733,9500
30 Sep 1530,3498538,2250
30 Jun 1530,2971,2837,9650
31 Mar 1530,1741,5308,0170
31 Dec 1430,5211,8497,8180
30 Sep 1431,0632,4697,6470
30 Jun 1430,8542,3567,9050
31 Mar 1430,0602,9387,5980
31 Dec 1329,1842,9197,4250
30 Sep 1327,8872,86912,0540
30 Jun 1326,4612,9379,8880
31 Mar 1325,8482,8818,1510

Quality Earnings: GLAXOSMITH has high quality earnings.

Growing Profit Margin: GLAXOSMITH's current net profit margins (4.6%) are higher than last year (3.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: GLAXOSMITH's earnings have declined by 1.9% per year over the past 5 years.

Accelerating Growth: GLAXOSMITH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: GLAXOSMITH had negative earnings growth (-27.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-11%).

Return on Equity

High ROE: GLAXOSMITH's Return on Equity (7.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/09 07:18
End of Day Share Price 2024/02/09 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GlaxoSmithKline Consumer Nigeria Plc is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Omotayo OyegunleCSL Stockbrokers Ltd
null nullFSDH Merchant Bank Limited
null nullMeristem Securities Limited